Haleon

Haleon is a global leader in the consumer healthcare industry, specializing in the research, development, and manufacturing of essential health products. While the company officially rebranded as Haleon in 2022, its operational roots trace back to 1715. Headquartered in Weybridge, United Kingdom, the firm maintains a robust international presence across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

The company manages a diverse portfolio of over-the-counter solutions, including oral health brands like Sensodyne, Polident, and Parodontax, alongside vitamins and supplements such as Centrum and Emergen-C. Haleon also provides respiratory and pain relief products, featuring well-known brands like Advil, Voltaren, and Theraflu. With a workforce of 10,000-20,000 employees, the organization operates through five primary locations globally. Meet Haleon's team to understand the leadership driving these complex pharmaceutical and healthcare operations.

Haleon competes in a highly saturated market against major entities such as Reckitt, Colgate-Palmolive, and Church & Dwight Co Inc. The company generates annual revenue of $14.9B, reflecting its significant market share in the consumer health sector. By focusing on digestive health, pain management, and preventative care, Haleon continues to expand its footprint in the global pharmaceutical landscape. The firm’s strategic focus remains on delivering high-quality consumer healthcare products that address diverse medical needs across multiple international markets.